Detalhe da pesquisa
1.
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy.
Cancer Metastasis Rev
; 39(3): 999-1013, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367253
2.
Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next-Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma-Derived Cell-Free Tumor DNA.
Oncologist
; 24(6): e387-e390, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670599
3.
Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
Cancers (Basel)
; 12(5)2020 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414097
4.
Early Evaluation of Response Using 18F-FDG PET Influences Management in Gastrointestinal Stromal Tumor Patients Treated with Neoadjuvant Imatinib.
J Nucl Med
; 59(2): 194-196, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28970330
5.
A single digital droplet PCR assay to detect multiple KIT exon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors.
Oncotarget
; 9(17): 13870-13883, 2018 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568401
6.
Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.
Eur J Cancer
; 86: 318-325, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073582
7.
Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.
Oncotarget
; 8(65): 109836-109847, 2017 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312652
8.
Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients.
Eur J Cancer
; 76: 76-83, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28284172